Publication|Articles|February 24, 2026

Psychiatric Times

  • Vol 43, Issue 2

Earn CME Credit With Psychiatric Times: Articles You Don’t Want to Miss

Listen
0:00 / 0:00

Key Takeaways

  • End-of-life care for psychiatric patients is more challenging than for psychiatrically healthy individuals, requiring specialized approaches.
  • Brexpiprazole is assessed for its efficacy in managing behavioral and psychological symptoms of dementia, which accelerate cognitive decline.
SHOW MORE

Don't miss out on these CME articles! Test your knowledge here.

If you need CME credit, check out these exclusive articles from Psychiatric Times before they expire. Answer the quiz questions to test your knowledge.

End-of-Life Care for Patients With Psychiatric Disorders

Joel Yager, MD; Jonathan Treem, MD; and Thomas Strouse, MD

Expiration Date: March 20, 2026

Caring for psychiatrically healthy individuals at the end of life is typically emotionally taxing and burdensome. Caring for individuals with psychiatric disorders at the end of life is often considerably more challenging.

1. Palliative care can improve which of the following?

Quality of life
Caregiver burden
End-of-life care outcomes
All of the above

Learn more here: https://www.psychiatrictimes.com/view/end-of-life-care-for-patients-with-psychiatric-disorders


Evaluating Brexpiprazole for the Management of Behavioral and Psychological Symptoms of Dementia

Anil K. Bachu, MD; Rashmi Phadke Subhedar, MD; Maliha I. Ansari, MD; Senthil Rajaram Manoharan, MD; and Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

Expiration Date: April 20, 2026

Behavioral and psychological symptoms of dementia are associated with a faster decline in cognition and function among individuals with dementia and contribute significantly to the greater rates of morbidity and mortality among those with dementia.

2. Fill in the blank: The term behavioral and psychological symptoms of dementia describes a constellation of symptoms and behaviors that occur in more than ___ of individuals with dementia.

90%
60%
25%
10%

Learn more here: https://www.psychiatrictimes.com/view/evaluating-brexpiprazole-for-the-management-of-behavioral-and-psychological-symptoms-of-dementia


Multidisciplinary Inpatient Care for Medically Compromised Youth and Young Adults With Eating Disorders

Jessica M. Pierce, MD, MSc; Vishvanie Bernadene Stoody, MD, MS; Christina Cwynar, DNP, CPNP-PC, PMHNP-B; Syma Khan, MSW; and Terrill Bravender, MD, MPH

Expiration Date: May 20, 2026

Caring for severely malnourished children and adolescents in the acute medical setting poses unique challenges, both for in-hospital management and longer-term care planning. Approaching the medical admission with a multidisciplinary team model from start to finish helps signal to patients and families that eating disorders are complex illnesses requiring not only medical stabilization and treatment but also comprehensive mental health, family, and social support interventions.

3. When a nasogastric tube is needed, it is left in place until the patient has been able to take in…

80% of their nutrition orally for at least 24 hours.
100% of their nutrition orally for at least 24 hours.
80% of their nutrition orally for at least 12 hours.
100% of their nutrition orally for at least 48 hours.

Learn more here: https://www.psychiatrictimes.com/view/multidisciplinary-inpatient-care-for-medically-compromised-youth-and-young-adults-with-eating-disorders


Demystifying Lithium Therapy—A Primer for Clinicians: Renal Issues, Part 1

Jonathan M. Meyer, MD, DLFAPA

Expiration Date: June 20, 2026

Lithium remains underused for the treatment of patients with a history of mania (eg, schizoaffective disorder, bipolar type, or bipolar I disorder). However, it remains the gold therapeutic standard as noted in treatment guidelines published since 2018.

4. What is the earliest manifestation of renal injury?

Stomach pain
Fainting
Polyuria
Headaches

Learn more here: https://www.psychiatrictimes.com/view/demystifying-lithium-therapy-a-primer-for-clinicians-renal-issues


Demystifying Lithium Therapy—A Primer for Clinicians: Lithium-Related Polyuria, Part 2

Jonathan M. Meyer, MD, DLFAPA

Expiration Date: July 20, 2026

Polyuria has a direct impact on various intracellular systems, resulting in vasopressin insensitivity and the downregulation of water-absorbing aquaporin 2 channels.

5. Early identification and treatment of polyuria with what drug should be offered to all patients treated with lithium?

Amiloride
Thiazide diuretics
Nonsteroidal anti-inflammatory drugs
Potassium supplements

Learn more here: https://www.psychiatrictimes.com/view/demystifying-lithium-therapy-a-primer-for-clinicians-lithium-related-polyuria-part-2


Are you interested in writing a CME article? Email us at [email protected]!

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.